Clinical Trials Directory

Trials / Completed

CompletedNCT07117071

Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.

Status
Completed
Phase
Study type
Observational
Enrollment
1,200 (actual)
Sponsor
Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) varies from 3.7 to 21.6% of adults depending on the population studied (country and age class), the method of diagnosis and the definition adopted. In the absence of available data for France, we analyzed the prevalence of Fuchs Endothelial Corneal Dystrophy (FECD) in a specific sub-population.

Detailed description

The Primary purpose is to Estimate the prevalence of Fuchs' endothelial dystrophy in the French population in dermatology population.

Conditions

Interventions

TypeNameDescription
OTHERcollection of medical datacollection of medical data : Age, Sex, Previous cataract surgery, Cellularity, Dermatological pathology, results of screening of Fuchs endothelial corneal dystrophy by Specular microscopy

Timeline

Start date
2024-01-02
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2025-08-12
Last updated
2025-08-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT07117071. Inclusion in this directory is not an endorsement.

Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients. (NCT07117071) · Clinical Trials Directory